Vincerx Pharma, Inc. (VINC) Tops Q4 EPS by 14c

Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q4 EPS of ($0.23), $0.14 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions